Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer

Affiliations

• ¹ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Personalised Oncology Division, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
• ² Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
• ³ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
• ⁴ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, Victoria, Australia.
• ⁵ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, Victoria, Australia; Victorian Adolescent and Young Adult Cancer Service, Melbourne, Victoria, Australia.
• ⁶ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Personalised Oncology Division, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: [email protected].